Bifidobacterium infantis

SEKINE K, OHTA J, ONIS M, TATSUKI T, SHIMOKAWA Y, TOIDA T, KAWASHIM T, HASHIMOTO Y (1995) Analysis of antitumor properties of effecter cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull. 18 148-53. 

Vitali, B., Wasinger, V., Brigidi, P., Guilhaus, M. (2005). A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry. Proteomics 5, 1859-1867. 

Figure 2.23 Effect of different doses of whole peptidoglycan (WPG) from Bifidobacterium infantis on the growth rate of Meth A tumour. Mice were inoculated subcutaneously with a mixture of 105 Meth A cells and 0 ( ), 10 (A), 20 (A), 25 (O), 50 ( ) or 100(D) M of WPG. (Modified from Tamura et al., 1993.)...

O Hara, A. M., O Regan, P., Fanning, A., O Mahony, C., MacSharry, J., Lyons, A., Bienenstock, J., O Mahony, L., and Shanahan, F. (2006). Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118, 202-215. 

Kowhi, Y., Imai, Z., Tamura, Z., and Hashimoto, Y., Antitumor effect of Bifidobacterium infantis in mice, Gann, 69, 613-618, 1978. 

There are two studies focusing on the analysis of the effect of prebiotics (both studies with the mixture of GOS/lcFOS) on the development of the different bifobac-teria species (48,54). In these studies, it could be demonstrated that the prebiotics promoted Bifidobacterium infantis and depressed B. adolescentis. In one study (48),... 

Sekine, K., Toida, T., Saito, M., Kuboyama, M., Kawashima, T., and Hashimoto, Y., A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an estabhshed tumor in mice. Cancer Res., 45,1300-1307,1985. 

Xylan Bacteroides ovatus Bacteroides fragilis subsp.a Bacteroides eggerthii Bacteroides vulgatus Bifidobacterium adolescentis Bifidobacterium infantis... 

Hung MN, Lee B. Purification and characterization of a recombinant beta-galactosidase with transga-lactosylation activity from Bifidobacterium infantis HL96. Appl Microbiol Biotechnol 2002 58(4) 439—45. 

Ewaschuk JB, Diaz H, Meddings L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. 

Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation... 

Nitropyrene Bacteroides sp., Bacteroides thetaiotaomicron, Bacteroides fragilis. Bifidobacterium infantis, Clostridium sp., Clostridium perfringens, Clostridium clostridiiforme, Clostridium leptum, Citrobacter sp., Peptococcus anaerobium, Peptostreptococcus productus. Salmonella typhimurium, Escherichia coli, Lactobacillus sp., Lactobacillus acidophilus. Rat and Human intestinal microflora. 1 -Aminopyrene, 1 -N-Acetyl-1 -aminopyrene, 1 -N-Formyl-1 -aminopyrene. 53, 36, 37, 13, 12, 45, 41, 44, 43, 64, 65, 10. 

Nitrobenzo[a]pyrene Bacteroides thetaiotaomicron. Bifidobacterium infantis, Clostridium sp., Citrobacter sp., Clostridium perfringens, Peptostreptococcus productus, Escherichia coli. Rat and Human intestinal microflora. 6-Aminobenzo[a]pyrene, 6-Nitrosobenzo[a]pyrene. 13, 12, 68, 27. 

---